Skip to main content
ACR Convergence 2025 Main banner
Final Program


Schedule at a Glance
Legend
Program: Scientific Session
General Topic: Clinical

From Biology to Community: Insights into Inflammatory Arthritis and the Complexities of Care in Indigenous Populations

Monday, October 27, 2025
2:30 PM – 3:30 PM Central Time

    Moderator(s)

  • CP

    Christopher Palma, MD

    University of Rochester
    Rochester, New York, United States

    Disclosure information not submitted.

  • Judith James, MD, PhD

    Oklahoma Medical Research Foundation
    Oklahoma City, Oklahoma, United States

    Disclosure(s): GlaxoSmithKlein(GSK): Consultant (Ongoing)

    • Session Coordinator(s)

  • CP

    Christopher Palma, MD

    University of Rochester
    Rochester, New York, United States

    Disclosure information not submitted.

  • Janet Pope, MD, FRCPC, MPH

    University of Western Ontario
    London, ON, Canada

    Disclosure(s): AbbVie/Abbott: Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Amgen: Advisor or Review Panel Member (Ongoing); AstraZeneca: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Boehringer-Ingelheim: Advisor or Review Panel Member (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Bristol-Myers Squibb(BMS): Consultant (Ongoing), Grant/Research Support (Ongoing); Eli Lilly: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Fresenius Kabi: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); GlaxoSmithKlein(GSK): Consultant (Ongoing); Horizon: Advisor or Review Panel Member (Ongoing); Janssen: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Merck/MSD: Consultant (Ongoing); Novartis: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing); Pfizer: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing), Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Sandoz: Speaker/Honoraria (includes speakers bureau, symposia, and expert witness) (Ongoing); Sanofi: Consultant (Ongoing); Therakos: Consultant (Ongoing), Grant/Research Support (Ongoing); UCB: Advisor or Review Panel Member (Ongoing), Consultant (Ongoing); Zura: Consultant (Ongoing)

A comprehensive look at the intersection of biology, care delivery, and cultural understanding in remote communities will provide valuable lessons for clinicians and researchers working with diverse populations.

Learning Objectives:

  • Identify the hurdles of research in remote communities and cultural sensitivities
  • Evaluate the types of research that can be developed with isolated populations
  • Recognize the unique biological factors influencing rheumatologic diseases in Alaska Native populations
  • Apply cultural competence, trust-building, and the reciprocal learning to enrich the practice and understanding of rheumatologic diseases.
  • Illustrate the role of cultural sensitivity and community engagement in improving health outcomes

Presentations:

  • 2:30 PM – 3:00 PM Central Time
    Tribulations of Developing "At-Risk" Rheumatoid Arthritis Cohorts in Remote Communities

    Speaker: Hani El-Gabalawy, MD, FRCPC – University of Manitoba

  • 3:00 PM – 3:30 PM Central Time
    Reflections from the North: Rheumatologic Care and Insights from Alaska Native Communities

    Speaker: John McDougall, Jr, MD, MHS – Northern Navajo Medical Center - Shiprock, NM